---
title: "Goldline Pharmaceutical (GLPL) — Share Price, Financials & Analysis"
symbol: "GLPL"
company: "Goldline Pharmaceutical"
canonical: "https://tapetide.com/stocks/GLPL"
isin: "INE1CLW01015"
bse_code: "GLPL"
market_cap_cr: 31.2
generated_at: "2026-10-13T10:57:30.567Z"
---

# Goldline Pharmaceutical (GLPL)

Canonical page: https://tapetide.com/stocks/GLPL

## Company

- **BSE Code:** GLPL
- **ISIN:** INE1CLW01015
- **F&O Eligible:** No

## Latest Price

- **Price:** ₹32.5
- **Change:** 0 (0%)
- **Open:** ₹32.5
- **Day High:** ₹32.5
- **Day Low:** ₹32.5
- **Previous Close:** ₹32.5
- **Volume:** 6000
- **As Of:** 2026-10-13T09:44:17+00:00

## Key Fundamentals

Price-based figures as of 2026-10-13T15:14:17+05:30.

Observed at 2026-10-13T04:34:05.961596Z.

- **Market Cap:** ₹31.2 Cr
- **Classification:** SME
- **P/E (TTM):** 10.16
- **EPS (TTM):** ₹3.2
- **Book Value:** ₹25.05
- **Price to Book:** 1.3
- **Dividend Yield:** 0%
- **ROE:** 28.89%
- **ROCE:** 39.98%
- **Debt to Equity:** 0.88
- **Revenue (yearly):** ₹31.2 Cr
- **Net Income:** ₹4.1 Cr
- **EBITDA:** ₹6.9 Cr
- **52-Week High:** ₹60
- **52-Week Low:** ₹28.5
- **RSI (14):** 40.78

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -11.64% | -3.77% | 126.29% |
| ebitda margin growth | 86.67% | 7.02% | 21.85% | — |
| net income growth | 111.11% | 46.43% | 119% | — |
| revenue growth | 30.67% | 11.03% | 16% | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2025 | Mar 2026 |
| --- | --- | --- |
| Sales | 13.89 | 17.31 |
| Expenses | 11.25 | 13 |
| Operating Profit | 2.64 | 4.31 |
| OPM % | 19.01 | 24.9 |
| Other Income | 0 | 0 |
| Interest | 0.67 | 0.65 |
| Depreciation | 0.12 | 0.12 |
| Profit before tax | 1.85 | 3.54 |
| Tax % | 26.49 | 21.75 |
| Net Profit | 1.36 | 2.76 |
| EPS in Rs | 1.97 | 4 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Sales | 19.73 | 23.48 | 28.01 | 31.18 |
| Expenses | 17.32 | 19.14 | 21.86 | 24.09 |
| Operating Profit | 2.41 | 4.34 | 6.15 | 7.09 |
| OPM % | 12.21 | 18.48 | 21.96 | 22.74 |
| Other Income | -0.2 | -0.04 | -0.09 | 0 |
| Interest | 1.63 | 1.61 | 1.95 | 1.46 |
| Depreciation | 0.18 | 0.16 | 0.25 | 0.24 |
| Profit before tax | 0.4 | 2.53 | 3.86 | 5.39 |
| Tax % | 37.5 | 28.46 | 26.42 | 23.38 |
| Net Profit | 0.26 | 1.81 | 2.83 | 4.12 |
| EPS in Rs | 1.3 | 7.87 | 4.1 | 5.97 |
| Dividend Payout % | 0 | 0 | 0 | 0 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Equity Capital | 2 | 2.3 | 6.9 | 6.9 |
| Reserves | 2.08 | 3.76 | 1.55 | 5.54 |
| Borrowings | 12.64 | 12.94 | 12.85 | 10.97 |
| Other Liabilities | 2.67 | 3.93 | 4.88 | 5.47 |
| Total Liabilities | 19.39 | 22.93 | 26.18 | 28.88 |
| Fixed Assets | 2.5 | 2.95 | 2.89 | 2.71 |
| CWIP | 0 | 0.45 | 0 | 0 |
| Investments | 0.07 | 0.03 | 0.03 | 0.03 |
| Other Assets | 16.82 | 19.5 | 23.26 | 26.14 |
| Total Assets | 19.39 | 22.93 | 26.18 | 28.88 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Cash from Operating Activity | 2.39 | 2.92 | 3.18 | 2.81 |
| Cash from Investing Activity | -1.04 | -1.11 | 0.16 | -0.06 |
| Cash from Financing Activity | -1.44 | -1.08 | -2.89 | -3.4 |
| Net Cash Flow | -0.09 | 0.74 | 0.45 | -0.65 |
| Free Cash Flow | 1.38 | 1.81 | 3.35 | 2.75 |
| CFO/OP | 101 | 72 | 66 | 53 |

### Ratios

| Item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- |
| Debtor Days | 159.65 | 149.54 | 139.3 | 188.82 |
| Inventory Days | 336.2 | 450.39 | 229.14 | 202.38 |
| Days Payable | 54.47 | 98.62 | 69.62 | 60.29 |
| Cash Conversion Cycle | 441.39 | 501.32 | 298.82 | 330.91 |
| Working Capital Days | 143.74 | 132.76 | 133.57 | 156.28 |
| ROCE % | — | 23.4 | 29.28 | 30.64 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2025 |
| --- | --- |
| Promoters | 79.71% |
| FIIs | 0% |
| DIIs | 0% |
| Government | 0% |
| Public | 0% |
| Others | 20.29% |
| No. of Shareholders | 20 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Sell
- **Buy / Neutral / Sell:** 3 / 9 / 7

### Moving Averages — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 32.12 | Buy |
| EMA (10) | 32.73 | Sell |
| SMA (20) | 33.9 | Sell |
| EMA (20) | 33.99 | Sell |
| SMA (50) | 37.66 | Sell |
| EMA (50) | 37.19 | Sell |
| SMA (100) | — | Neutral |
| EMA (100) | — | Neutral |
| SMA (200) | — | Neutral |
| EMA (200) | — | Neutral |

### Oscillators — summary: **Neutral**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 40.78 | Neutral |
| MACD (12,26,9) | -1.79 | Buy |
| Stochastic (14,3,3) | 55.49 | Neutral |
| ADX (14) | 28.01 | Buy |
| Williams %R (14) | -38.46 | Neutral |
| ATR (14) | 1.89 | High Volatility |
| ROC (12) | -2.43 | Sell |
| Stoch RSI (14) | 82.51 | Sell |
| UO (7,14,28) | 56.96 | Neutral |

## Filings & Documents

### Credit Rating Reports

| Date | Document |
| --- | --- |
| 2025-07-28 | Credit rating update — CRISIL |
| 2024-05-24 | Credit rating update — CRISIL |
| 2023-03-14 | Credit rating update — CRISIL |
| 2022-01-21 | Credit rating update — CRISIL |
| 2020-10-19 | Credit rating update — CRISIL |
| 2020-08-25 | Credit rating update — CRISIL |

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-10-12 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7a7857e4-28de-4d16-976e-18bef539ff56.pdf) |
| 2026-09-24 | [Closure of Trading Window](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2944c9c0-8ac7-40d5-9ff9-5f2dd04313c4.pdf) |
| 2026-09-02 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6E9F6F28_0A9A_4A6C_A18C_CAFFE86C6A36_110951.pdf) |
| 2026-09-02 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E5E3FED7_C90E_469E_84AF_4D96362BF8FE_111210.pdf) |
| 2026-09-01 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=CC09DD57_CCC2_4F19_9207_E29A5238A294_131127.pdf) |
| 2026-08-31 | [Shareholder Meeting / Postal Ballot-Scrutinizers Report](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ba4a2c5-39d3-471b-b37c-287edd2a434e.pdf) |
| 2026-08-29 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5F29FC99_0E81_44E1_A399_30B74A14542B_170251.pdf) |
| 2026-08-29 | [Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3626A079_E87F_4B1A_B859_82B5ADF3BC70_170355.pdf) |
| 2026-08-29 | [Shareholder Meeting / Postal Ballot-Outcome of AGM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3d2b1b88-99d3-4b5a-9bd5-4bf597d50b2a.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3df7bec-8363-44ab-8962-486a61acb66b.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-06-09 | [Outcome Of Board Meeting Held Today I.E. 09Th June 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8bf8c4ae-b0fb-4c51-81fb-8f5be0e0a763.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-10-13T10:57:30.567Z.